Advanced search
Publication Cover
Journal of Chemotherapy Volume 36, 2024 - Issue 1
Submit an article Journal homepage
66
Views
0
CrossRef citations to date
0
Altmetric
Letter to Editor

MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer

Kyoichi Kairaa Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka City, JapanCorrespondence[email protected]
,
Tomohiro Ikezawab Department of Nephrology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Moroyama-cho, Japan
,
Tsutomu Inoueb Department of Nephrology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Moroyama-cho, Japan
,
Hisao Imaia Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka City, Japan
,
Hirokazu Okadab Department of Nephrology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Moroyama-cho, Japan
&
Hiroshi Kagamua Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka City, Japan
Pages 82-83 | Received 14 Feb 2023, Accepted 27 Apr 2023, Published online: 14 May 2023

References

  • Gallan AJ, Alexander E, Reid P, et al. Renal vasculitis and pauci-immune glomerulonephritis associated with immune checkpoint inhibitors. Am J Kidney Dis. 2019;74(6):853–856.
  • Heo MH, Kim HK, Lee H, et al. Antineutrophil cytoplasmic antibody-associated rapid progressive glomerulonephritis after pembrolizumab treatment in thymic epithelial tumor: a case report. J Thorac Oncol. 2017;12(8):e103–e105.
  • Mamlouk O, Selamet U, Machado S, et al. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single center experience. J Immunother Cancer. 2019;7:2.
  • Uner M, Alhasson B, Obhrai J, et al. ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab. Virchows Arch. 2021;478(4):801–804.
  • Aqeel F, Monroy-Trujillo J, Geetha D. Immune checkpoint inhibitors as potential triggers for ANCA vasculitis. RMD Open. 2022;8(2):e002500.
  • Laamech R, Terrec F, Emprou C, et al. Efficacy of plasmapheresis in Nivolumab-Associated ANCA glomerulonephritis: a case report and pathophysiology discussion. Case Rep Nephrol Dial. 2021;11(3):376–383.
  • Cortazar FB, Marrone KA, Troxell ML, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90(3):638–647.
  • Kitchlu A, Jhaveri KD, Wadhwani S, et al. A systemic review of immune checkpoint inhibitor-associated glomerular disease. Kidney Int Rep. 2021;6(1):66–77.
  • Valenzuela LM, Draibe JB, Oliveras XF, et al. T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach. Clin Kidney J. 2019;12:503–511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.